LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles
If I had to buy just one FTSE 100 stock in 2024, it would be this

Investing Articles
Are these 2 FTSE 100 companies recession-resistant?

Investing Articles
Here’s a FTSE 100 giant I’m eyeing up for December!

Investing Articles
Here’s 1 thriving FTSE 100 stock I’d snap up in November

Value Shares
UK shares near 52-week lows: 2 I like and 1 I’d avoid

Investing Articles
Does the AstraZeneca share price scream value?

Investing Articles
After a rocky October, are AstraZeneca shares now a buy?

Investing Articles
What’s going on with the AstraZeneca share price?

Investing Articles
Will litigation news help to move the AstraZeneca share price?

Investing Articles
Which is the best value stock now: AstraZeneca or GSK?

Investing Articles
Down 14%! Should I buy the dip in the AstraZeneca share price?
